These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34833498)

  • 1. Changes in the Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1(APE1/Ref-1) Level during Cancer Surgery: An Observational Study.
    Jo Y; Kim Y; Park E; Lee Y; Kim J; Kang M; Lim J; Song I; Lim C; Jeon B
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833498
    [No Abstract]   [Full Text] [Related]  

  • 2. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
    Xie J; Li Y; Kong J; Li C
    J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
    Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
    Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
    Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
    Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.
    Curtis CD; Thorngren DL; Ziegler YS; Sarkeshik A; Yates JR; Nardulli AM
    Mol Endocrinol; 2009 Sep; 23(9):1346-59. PubMed ID: 19460860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.
    Baek H; Lim CS; Byun HS; Cho HS; Lee YR; Shin YS; Kim HW; Jeon BH; Kim DW; Hong J; Hur GM; Park JB
    Mol Brain; 2016 Dec; 9(1):99. PubMed ID: 27986089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
    Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH
    Cancer Res Treat; 2015 Oct; 47(4):823-33. PubMed ID: 25672588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
    Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
    Kaur G; Cholia RP; Mantha AK; Kumar R
    J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
    Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
    Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.
    Sahakian L; Robinson AM; Sahakian L; Stavely R; Kelley MR; Nurgali K
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.
    Akhter N; Takeda Y; Nara H; Araki A; Ishii N; Asao N; Asao H
    J Biol Chem; 2016 Nov; 291(45):23672-23680. PubMed ID: 27637330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease.
    Lee YR; Bae EY; Kil HR; Jeon BH; Kim G
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
    Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
    J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
    Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
    Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the N-terminal domain of human apurinic/apyrimidinic endonuclease 1, APE1, in DNA glycosylase stimulation.
    Kladova OA; Bazlekowa-Karaban M; Baconnais S; Piétrement O; Ishchenko AA; Matkarimov BT; Iakovlev DA; Vasenko A; Fedorova OS; Le Cam E; Tudek B; Kuznetsov NA; Saparbaev M
    DNA Repair (Amst); 2018 Apr; 64():10-25. PubMed ID: 29475157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.